Previous close | 24.76 |
Open | 22.69 |
Bid | 22.05 x 500 |
Ask | 22.20 x 500 |
Day's range | 20.19 - 23.56 |
52-week range | 20.19 - 59.61 |
Volume | |
Avg. volume | 750,783 |
Market cap | 1.07B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript May 2, 2024 AtriCure, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to AtriCure’s First Quarter 2024 Earnings Conference Call. This call is being recorded for replay […]
Discover how AtriCure Inc achieved a 16% revenue increase and nearly 50% rise in adjusted EBITDA in the first quarter of 2024, alongside strategic product advancements.
The headline numbers for AtriCure (ATRC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.